Learn

Scientific posters, manuscripts and webinars

Peer-reviewed publications and conference posters authored by our dedicated team of
oncologists, pathologists and scientists.

Webinar  -  5 February 2025

Molecular Tumor Board: 47-year-old male with papillary thyroid cancer and BRAF V600E alteration

Read Moreabout Molecular Tumor Board: 47-year-old male with papillary thyroid cancer and BRAF V600E alteration

Peer-Reviewed Publication  -  14 January 2025

Analytical Validation of the Labcorp Plasma Complete Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology

Read Moreabout Analytical Validation of the Labcorp Plasma Complete Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology

Article  -  9 January 2025

Graphical Summary: Comprehensive assessment of immune phenotype and its effects on survival outcomes in HER2-low versus HER2-zero breast cancer

Read Moreabout Graphical Summary: Comprehensive assessment of immune phenotype and its effects on survival outcomes in HER2-low versus HER2-zero breast cancer

Webinar  -  6 December 2024

Molecular Tumor Board: 82-year-old female with high grade ovarian serous adenocarcinoma and BRCA1 F709fs mutation

Read Moreabout Molecular Tumor Board: 82-year-old female with high grade ovarian serous adenocarcinoma and BRCA1 F709fs mutation

Article  -  6 December 2024

Graphical Summary: Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer

Read Moreabout Graphical Summary: Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer

Webinar  -  6 December 2024

Molecular Tumor Board: 38-year-old female with follicular thyroid cancer and NRAS Q61R alteration

Read Moreabout Molecular Tumor Board: 38-year-old female with follicular thyroid cancer and NRAS Q61R alteration

Peer-Reviewed Publication  -  3 December 2024

Analysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancers

Read Moreabout Analysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancers

Peer-Reviewed Publication  -  26 November 2024

Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1

Read Moreabout Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1

Poster  -  23 November 2024

Analytical validation of OmniSeq® INSIGHT whole transcriptome sequencing assay to facilitate precision oncology through tumoronly testing in solid tumors

Read Moreabout Analytical validation of OmniSeq® INSIGHT whole transcriptome sequencing assay to facilitate precision oncology through tumoronly testing in solid tumors